PatinaInsurance
Disclaimer
Patina Insurance does not sell, solicit, or negotiate insurance products. All recommendations and referrals are for informational purposes only.
Patina Insurance, Your Trusted Insurance Advisor Since 2013
07/29/2026
"Tomorrow's Concerns, Today's Certainties."
60 Years of the Older Americans Act: What’s in It for You? The landmark law created a network of community-based support programs for older adults in the U.S.
07/21/2026
"Tomorrow's Concerns, Today's Certainties."
AARP Backs Bill to Limit Original Medicare Costs Medicare Advantage already has out-of-pocket limits
07/21/2026
"Tomorrow's Concerns, Today's Certainties."
High LDL Cholesterol Could Raise Dementia Risk “Bad” cholesterol isn’t just a heart concern; it’s a brain issue. Taking steps to lower LDL may help protect both body and mind
07/21/2026
"Tomorrow's Concerns, Today's Certainties."
Summer is in full swing — make sure you know the signs of heat-related illness! If you’re outside and start feeling dizzy, weak, or nauseated, go inside or seek help. Learn how to stay safe in the heat: https://go.medicare.gov/4pa9GIg
07/21/2026
Unique Pharmaceutical Laboratories Issues Voluntary of Cetirizine Hydrochloride Tablets USP 5 mg Due to Potential Cross Contamination with Ranitidine
https://www.drugs.com/fda/unique-pharmaceutical-laboratories-issues-voluntary-nationwide-recall-cetirizine-hydrochloride-usp-14818.html?hash2=5ec84a3eecae5b6377f0b7729dc8c76f&utm_source=ddc&utm_medium=email&utm_campaign=FDA+Safety+Alert++Unique+Pharmaceutical+Laboratories+Issues+Voluntary+Nationwide+Recall+of+Cetirizine+Hydrochloride+Tablets+USP+5+mg+Due+to+Potential+Cross+Contamination+with+Ranitidine
07/13/2026
July is National Blueberry Month! Blueberries are nutrient-dense and a great source of fiber, vitamin C, and vitamin K, so add them as part of a balanced diet.
07/13/2026
FDA Alerts Health Care Providers to Cases of Neurologic Complications Linked to Genetic Variant in Patients of Maternal Venezuelan Ancestry.
FDA Alert: FDA Alerts Health Care Providers to Cases of Neurologic Complications from General Anesthesia Linked to Genetic Variant in Patients of Maternal Venezuelan Ancestry July 2, 2026 -- The U.S. Food and Drug Administration (FDA) is investigating the safety of sevoflurane and other general anesthetics based on published scientific reports of unexpected catastrophic outcomes, including severe neurologic adverse outcomes and death, occurring in adult and pediatric pat...
07/03/2026
Making decisions about health and life insurance is a careful process. That’s why it’s important for employers and their employees to consider the advantages of Employer Group Benefits and the positive impact they may have.
Learn more about our Employer Group Benefits on the ManhattanLife website at: https://www.manhattanlife.com/products/employers
You can also email us at [email protected]
07/03/2026
Breaking decades of stagnation in brain cancer research NewYork-Presbyterian's GLICO seeks to overcome glioblastoma's resistance by mimicking brain environments to test treatments more effectively.
06/17/2026
FDA Approves Labeling Changes for Over-the-Counter (OTC) Weight Loss Drug alli (Orlistat) to Warn of Risk of Kidney Stones and Kidney Injury
Audience: Consumer, , Health Care , , Gastroenterology, Nephrology, Endocrinology
https://www.drugs.com/fda/fda-approves-labeling-changes-over-counter-otc-weight-loss-alli-orlistat-warn-risk-kidney-stones-14814.html?hash2=5ec84a3eecae5b6377f0b7729dc8c76f&utm_source=ddc&utm_medium=email&utm_campaign=FDA+Safety+Alert++FDA+Approves+Labeling+Changes+for+Over+the+Counter++OTC++Weight+Loss+Drug+alli++Orlistat++to+Warn+of+Risk+of+Kidney+Stones+and+Kidney+Injury
Click here to claim your Sponsored Listing.